Clinical Pharmacokinetics of Drugs Used in Juvenile Arthritis
- 1 August 1991
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 21 (2) , 129-149
- https://doi.org/10.2165/00003088-199121020-00004
Abstract
Juvenile arthritis is defined as the occurrence of objective evidence of arthritis for a minimum of 6 weeks, in a child 16 years of age or younger. With a reported incidence of 9 to 19.6 per 100 000...Keywords
This publication has 99 references indexed in Scilit:
- Clinical Pharmacokinetics of Ketoprofen and Its EnantiomersClinical Pharmacokinetics, 1990
- Pharmacokinetics of Common Analgesics, Anti-Inflammatories and Antipyretics in ChildrenClinical Pharmacokinetics, 1989
- Nonsteroidal Anti‐Inflammatory Drugs in the Management of Juvenile ArthritisThe Journal of Clinical Pharmacology, 1988
- Determinants of low serum concentrations of salicylates in patients with Kawasaki diseaseThe Journal of Pediatrics, 1988
- Diclofenac SodiumDrugs, 1988
- Metabolic acidosis after acute ibuprofen overdosageThe Journal of Pediatrics, 1987
- Clinical Pharmacokinetics of D-PenicillamineClinical Pharmacokinetics, 1987
- Ibuprofen overdose: 126 casesAnnals of Emergency Medicine, 1986
- Clinical Pharmacokinetics of Sulphasalazine, Its Metabolites and Other Prodrugs of 5-Aminosalicylic AcidClinical Pharmacokinetics, 1985
- Comparison of tolmetin sodium and aspirin in the treatment of juvenile rheumatoid arthritisThe Journal of Pediatrics, 1977